Cagrilintide

The right amount depends on vial size and the target concentration a researcher wants to work with — for example, a 5 mg vial is commonly reconstituted with around 2 mL of bacteriostatic water, while a 10 mg vial is often reconstituted with around 3 mL. There's no single "correct" volume; more diluent simply spreads the same total peptide across a larger volume, which can make small-volume measurements easier. Use a sterile technique and consult our dosage calculator for the specific math.

Once reconstituted, cagrilintide (like most peptides) is generally kept refrigerated at approximately 2-8°C (36-46°F) and protected from light, with typical stability windows cited around 28 days under those conditions. Unreconstituted lyophilized powder is usually stored frozen or refrigerated until use. These are general peptide-handling guidelines, not medical storage instructions.

Across clinical studies, the most commonly reported effects were gastrointestinal — nausea, vomiting, constipation, diarrhea, and abdominal discomfort — along with injection-site reactions, with GI effects generally described as mild to moderate and more common at higher doses. This information reflects published trial data and is provided for research awareness only; it is not medical guidance.

Cagrilintide is not currently FDA-approved for any use and remains an investigational compound studied in clinical trials rather than a prescribed medication. It is sold by vendors, including those compared on this page, as a research chemical intended for laboratory and research purposes only, not for human or animal consumption. Buyers are responsible for understanding and complying with the laws in their own jurisdiction.

The clinically studied amylin combination is cagrilintide plus semaglutide (CagriSema); there is currently no FDA-approved or large-scale published human trial specifically combining cagrilintide with tirzepatide. Because cagrilintide's amylin pathway is mechanistically distinct from GLP-1/GIP pathways, researchers have theorized additive effects, but combining any two appetite-related compounds can also amplify gastrointestinal side effects. This is an active research question, not an established protocol.

Key factors include third-party purity/COA testing, verified vial size and labeled concentration, reviews or reputation, pricing per mg, and clear "for research use only" labeling and disclaimers. The vendor comparison table on this page is designed to help evaluate these factors side by side across multiple suppliers.